speb/financial-data huggingface dataset:
COV.V cash_flow (annual, 2025-09-30) — Purchase Of PPE: -644178.00
COV.V cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -114000.00
COV.V balance_sheet (annual, 2025-09-30) — Raw Materials: 4065394.00
COV.V balance_sheet (quarterly, 2025-09-30) — Raw Materials: 4065394.00
COV.V balance_sheet (annual, 2025-09-30) — Receivables: 5927319.00
COV.V balance_sheet (quarterly, 2025-09-30) — Receivables: 5927319.00
COV.V income_statement (annual, 2025-09-30) — Reconciled Cost Of Revenue: 15344483.00
COV.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 4246575.00
COV.V income_statement (annual, 2025-09-30) — Reconciled Depreciation: 954943.00
COV.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 248144.00
COV.V cash_flow (annual, 2025-09-30) — Repayment Of Debt: -758035.00
COV.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -215339.00
COV.V income_statement (annual, 2025-09-30) — Research And Development: 1319949.00
COV.V income_statement (quarterly, 2025-09-30) — Research And Development: 314811.00
COV.V balance_sheet (annual, 2025-09-30) — Retained Earnings: -33638402.00
COV.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -33638402.00
COV.V income_statement (annual, 2025-09-30) — Selling And Marketing Expense: 4752410.00
COV.V income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1171363.00
COV.V income_statement (annual, 2025-09-30) — Selling General And Administration: 12421306.00
COV.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3641146.00
COV.V balance_sheet (annual, 2025-09-30) — Share Issued: 27418077.00
COV.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 27418077.00
COV.V cash_flow (annual, 2025-09-30) — Stock Based Compensation: 274075.00
COV.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 63634.00
COV.V balance_sheet (annual, 2025-09-30) — Stockholders Equity: 30726909.00
COV.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 30726909.00
COV.V balance_sheet (annual, 2025-09-30) — Tangible Book Value: 29376235.00
COV.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 29376235.00
COV.V income_statement (annual, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
COV.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
COV.V income_statement (annual, 2025-09-30) — Tax Rate For Calcs: 0.15
COV.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
COV.V balance_sheet (annual, 2025-09-30) — Total Assets: 36123587.00
COV.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 36123587.00
COV.V balance_sheet (annual, 2025-09-30) — Total Capitalization: 30726909.00
COV.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 30726909.00
COV.V balance_sheet (annual, 2025-09-30) — Total Debt: 2253740.00
COV.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 2253740.00
COV.V balance_sheet (annual, 2025-09-30) — Total Equity Gross Minority Interest: 30726909.00
COV.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 30726909.00
COV.V income_statement (annual, 2025-09-30) — Total Expenses: 31052675.00
COV.V income_statement (quarterly, 2025-09-30) — Total Expenses: 8446126.00
COV.V balance_sheet (annual, 2025-09-30) — Total Liabilities Net Minority Interest: 5396678.00
COV.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 5396678.00
COV.V balance_sheet (annual, 2025-09-30) — Total Non Current Assets: 4592737.00
COV.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4592737.00
COV.V balance_sheet (annual, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1626484.00
COV.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1626484.00
COV.V income_statement (annual, 2025-09-30) — Total Other Finance Cost: -444107.00
COV.V income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: -112491.00
COV.V balance_sheet (annual, 2025-09-30) — Tradeand Other Payables Non Current: 0.00
COV.V balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 0.00
COV.V balance_sheet (annual, 2025-09-30) — Working Capital: 27760656.00
COV.V balance_sheet (quarterly, 2025-09-30) — Working Capital: 27760656.00
COV.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 3955987.00
COV.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 6888302.00
COV.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 2183719.00
COV.V balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -2880019.00
COV.V balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 8350948.00
COV.V cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 72914.00
COV.V cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 72914.00
COV.V income_statement (quarterly, 2025-12-31) — Basic Average Shares: 27576319.00
COV.V income_statement (quarterly, 2025-12-31) — Basic EPS: 0.00
COV.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 17367288.00
COV.V balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 1809994.00
COV.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -718552.00
COV.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2065071.00
COV.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 52105143.00
COV.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 17878098.00
COV.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 17878098.00
COV.V cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -4142712.00
COV.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4322221.00
COV.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -718552.00
COV.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 5751950.00
COV.V cash_flow (quarterly, 2025-12-31) — Change In Inventory: 498825.00
COV.V cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 527786.00
COV.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 629727.00
COV.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -34087.00
COV.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: 3611955.00
COV.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 5234206.00
COV.V cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 3611955.00
COV.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: 711177.00
COV.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 52105143.00
COV.V cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -4142712.00
COV.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 26391645.00
COV.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2880071.00
COV.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 27744368.00
COV.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 530394.00
COV.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 530394.00
COV.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 530800.00
COV.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 530800.00
COV.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 4872800.00
COV.V cash_flow (quarterly, 2025-12-31) — Depreciation: 169603.00
COV.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 242517.00
COV.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 242517.00
COV.V income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 27773157.00
COV.V income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.00
COV.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 125377.00
COV.V income_statement (quarterly, 2025-12-31) — EBIT: 52244.00
COV.V income_statement (quarterly, 2025-12-31) — EBITDA: 294761.00
COV.V cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -200367.00
COV.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 17878098.00
COV.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -4322221.00
COV.V balance_sheet (quarterly, 2025-12-31) — Finished Goods: 3176164.00
COV.V balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: 3591291.00
COV.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 5033398.00
COV.V cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 50585.00
COV.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 3591291.00
COV.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1965093.00
COV.V balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1324165.00
COV.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 6610608.00
COV.V income_statement (quarterly, 2025-12-31) — Gross Profit: 4008231.00
COV.V income_statement (quarterly, 2025-12-31) — Interest Income: 123718.00
COV.V income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 123718.00
COV.V balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -364895.00
COV.V balance_sheet (quarterly, 2025-12-31) — Inventory: 6822490.00
COV.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 26391645.00
COV.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -718552.00
COV.V cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 34220.00
COV.V balance_sheet (quarterly, 2025-12-31) — Leases: 423954.00
COV.V balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1534677.00
COV.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1534677.00
COV.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 34220.00
COV.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -213729.00
COV.V balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 544042.00
COV.V income_statement (quarterly, 2025-12-31) — Net Income: 125377.00
COV.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 125377.00
COV.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 125377.00
COV.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 125377.00
COV.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 125377.00
COV.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 125377.00
COV.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 125377.00
COV.V cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -66005.00
COV.V income_statement (quarterly, 2025-12-31) — Net Interest Income: 123718.00
COV.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -179509.00
COV.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -179509.00
COV.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 123718.00
COV.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 3730589.00
COV.V cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -652547.00
COV.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 25067480.00
COV.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 294761.00
COV.V income_statement (quarterly, 2025-12-31) — Normalized Income: 125377.00
COV.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 5751950.00
COV.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 50585.00
COV.V income_statement (quarterly, 2025-12-31) — Operating Income: 52244.00
COV.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 6888302.00
COV.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 27618077.00
COV.V income_statement (quarterly, 2025-12-31) — Other Gand A: 1965093.00
COV.V income_statement (quarterly, 2025-12-31) — Other Income Expense: -50585.00
COV.V balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1324165.00
COV.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 31735.00
COV.V income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -50585.00
COV.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 689707.00
COV.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 3832618.00
COV.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3811606.00
COV.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 860061.00
COV.V income_statement (quarterly, 2025-12-31) — Pretax Income: 125377.00
COV.V balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
COV.V cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -66005.00
COV.V cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -652547.00
COV.V balance_sheet (quarterly, 2025-12-31) — Raw Materials: 4011221.00
COV.V balance_sheet (quarterly, 2025-12-31) — Receivables: 2183719.00
COV.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2880071.00
COV.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 242517.00
COV.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -213729.00
COV.V income_statement (quarterly, 2025-12-31) — Research And Development: 289258.00
COV.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -37655737.00
COV.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 1011929.00
COV.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2977022.00
COV.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 27618077.00
COV.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 67530.00
COV.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 26391645.00
COV.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 25067480.00
COV.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
COV.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
COV.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 32799122.00
COV.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 26391645.00
COV.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 2065071.00
COV.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 26391645.00
COV.V income_statement (quarterly, 2025-12-31) — Total Expenses: 6836058.00
COV.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 6407477.00
COV.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 5054754.00
COV.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1534677.00
COV.V balance_sheet (quarterly, 2025-12-31) — Working Capital: 22871568.00
COV.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 4443400.00
COV.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 8727014.00
COV.V balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4696622.00
COV.V balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -2999460.00
COV.V balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 8422327.00
COV.V cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 72986.00
COV.V cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 72986.00
COV.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 27618077.00
COV.V income_statement (quarterly, 2026-03-31) — Basic EPS: 0.04
COV.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 17878098.00
COV.V balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 1679312.00
COV.V cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -209337.00
COV.V balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1773551.00
COV.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 52105143.00
COV.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 16567898.00
COV.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 16567898.00
COV.V cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
COV.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -215473.00
COV.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -209337.00
COV.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -1151497.00
COV.V cash_flow (quarterly, 2026-03-31) — Change In Inventory: 526744.00
COV.V cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -416850.00
COV.V cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -489236.00
COV.V cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 361835.00
COV.V cash_flow (quarterly, 2026-03-31) — Change In Receivables: -2470848.00
COV.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2488355.00
COV.V cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -2470848.00
COV.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1576307.00
COV.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 52105143.00
COV.V cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: 0.00
COV.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 28017651.00
COV.V income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3363625.00
COV.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 28148161.00
COV.V balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 332028.00
COV.V balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 332028.00
COV.V balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 109965.00
COV.V balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 109965.00
COV.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3720701.00
COV.V cash_flow (quarterly, 2026-03-31) — Depreciation: 171103.00
COV.V cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 244089.00
COV.V income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 178612.00
COV.V cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 244089.00
COV.V income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 178612.00
COV.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 27723580.00
COV.V income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.04
COV.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1093449.00
COV.V income_statement (quarterly, 2026-03-31) — EBIT: 919989.00
COV.V income_statement (quarterly, 2026-03-31) — EBITDA: 1164078.00
COV.V cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 266107.00
COV.V cash_flow (quarterly, 2026-03-31) — End Cash Position: 16567898.00
COV.V cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -215473.00
COV.V balance_sheet (quarterly, 2026-03-31) — Finished Goods: 3267791.00
COV.V balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: 4052469.00
COV.V cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -1360834.00
COV.V cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 0.00
COV.V balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 4052469.00
COV.V income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1828841.00
COV.V balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1307969.00
COV.V balance_sheet (quarterly, 2026-03-31) — Gross PPE: 6723205.00
COV.V income_statement (quarterly, 2026-03-31) — Gross Profit: 5363389.00
COV.V balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -455307.00
COV.V balance_sheet (quarterly, 2026-03-31) — Inventory: 6376972.00
COV.V balance_sheet (quarterly, 2026-03-31) — Invested Capital: 28017651.00
COV.V cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -209337.00
COV.V cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
COV.V balance_sheet (quarterly, 2026-03-31) — Leases: 432687.00
COV.V balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1441523.00
COV.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1441523.00
COV.V cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
COV.V cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -215473.00
COV.V balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 580772.00
COV.V income_statement (quarterly, 2026-03-31) — Net Income: 1093449.00
COV.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1093449.00
COV.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1093449.00
COV.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1093449.00
COV.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1093449.00
COV.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1093449.00
COV.V income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1093449.00
COV.V cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -36574.00
COV.V income_statement (quarterly, 2026-03-31) — Net Interest Income: 73957.00
COV.V cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -215473.00
COV.V cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -215473.00
COV.V income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 73957.00
COV.V balance_sheet (quarterly, 2026-03-31) — Net PPE: 3723745.00
COV.V cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -172763.00
COV.V balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 26709682.00
COV.V income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1064575.00
COV.V income_statement (quarterly, 2026-03-31) — Normalized Income: 1033747.20
COV.V cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -1151497.00
COV.V cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 0.00
COV.V income_statement (quarterly, 2026-03-31) — Operating Income: 919989.00
COV.V income_statement (quarterly, 2026-03-31) — Operating Revenue: 8727014.00
COV.V balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 27618077.00
COV.V income_statement (quarterly, 2026-03-31) — Other Gand A: 1828841.00
COV.V income_statement (quarterly, 2026-03-31) — Other Income Expense: 99503.00
COV.V balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1307969.00
COV.V cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -72059.00
COV.V income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 931471.00
COV.V balance_sheet (quarterly, 2026-03-31) — Other Properties: 4030434.00
COV.V income_statement (quarterly, 2026-03-31) — Other Special Charges: -99503.00
COV.V balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 3278708.00
COV.V balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 506669.00
COV.V income_statement (quarterly, 2026-03-31) — Pretax Income: 1093449.00
COV.V balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
COV.V cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -36574.00
COV.V cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -172763.00
COV.V balance_sheet (quarterly, 2026-03-31) — Raw Materials: 3564488.00
COV.V balance_sheet (quarterly, 2026-03-31) — Receivables: 4696622.00
COV.V income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3298148.00
COV.V income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 244089.00
COV.V cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -215473.00
COV.V income_statement (quarterly, 2026-03-31) — Research And Development: 337794.00
COV.V balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -36562288.00
COV.V income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1166682.00
COV.V income_statement (quarterly, 2026-03-31) — Selling General And Administration: 2995523.00
COV.V balance_sheet (quarterly, 2026-03-31) — Share Issued: 27618077.00
COV.V income_statement (quarterly, 2026-03-31) — Special Income Charges: 99503.00
COV.V cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 71379.00
COV.V balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 28017651.00
COV.V balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 26709682.00
COV.V income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 39801.20
COV.V income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
COV.V balance_sheet (quarterly, 2026-03-31) — Total Assets: 33179875.00
COV.V balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 28017651.00
COV.V balance_sheet (quarterly, 2026-03-31) — Total Debt: 1773551.00
COV.V balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 28017651.00
COV.V income_statement (quarterly, 2026-03-31) — Total Expenses: 7807025.00
COV.V balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 5162224.00
COV.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 5031714.00
COV.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1441523.00
COV.V income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -73957.00
COV.V income_statement (quarterly, 2026-03-31) — Total Unusual Items: 99503.00
COV.V income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 99503.00
COV.V balance_sheet (quarterly, 2026-03-31) — Working Capital: 24427460.00
COVH.PA balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -16947000.00
COVH.PA cash_flow (annual, 2021-12-31) — Capital Expenditure Reported: -73752000.00
COVH.PA cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -34458000.00
COVH.PA balance_sheet (annual, 2021-12-31) — Construction In Progress: 4982000.00
COVH.PA balance_sheet (annual, 2021-12-31) — Other Equity Interest: 1000.00
COVH.PA balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 1000.00
COVH.PA income_statement (annual, 2022-12-31) — +Operating Expense: 45348000.00
COVH.PA income_statement (annual, 2022-12-31) — +Total Revenue: 466501000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Accounts Payable: 43488000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Accounts Receivable: 37827000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1700621000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -6258000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 42946000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 1157000.00
COVH.PA income_statement (annual, 2022-12-31) — Basic Average Shares: 148131771.00
COVH.PA income_statement (annual, 2022-12-31) — Basic EPS: 3.23
COVH.PA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 144259000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 1111341000.00
COVH.PA cash_flow (annual, 2022-12-31) — Capital Expenditure: -71056000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 281401000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Capital Stock: 592566000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 127408000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 127408000.00
COVH.PA cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -96286000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Cash Equivalents: 1200000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Cash Financial: 126208000.00
COVH.PA cash_flow (annual, 2022-12-31) — Change In Inventory: -527000.00
COVH.PA cash_flow (annual, 2022-12-31) — Change In Payable: -35096000.00
COVH.PA cash_flow (annual, 2022-12-31) — Change In Receivables: 18426000.00
COVH.PA cash_flow (annual, 2022-12-31) — Change In Working Capital: -17197000.00
COVH.PA cash_flow (annual, 2022-12-31) — Changes In Cash: -26353000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Common Stock: 592566000.00
COVH.PA cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -96286000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 3577832000.00
COVH.PA cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
COVH.PA cash_flow (annual, 2022-12-31) — Common Stock Payments: -24000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Construction In Progress: 5387000.00
COVH.PA income_statement (annual, 2022-12-31) — Cost Of Revenue: 171319000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Current Assets: 319776000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 5253000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Current Debt: 294523000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 299776000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 1284000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Current Liabilities: 459919000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Current Provisions: 12322000.00
COVH.PA cash_flow (annual, 2022-12-31) — Deferred Tax: 5577000.00
COVH.PA cash_flow (annual, 2022-12-31) — Depreciation: 41144000.00
COVH.PA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 41144000.00
COVH.PA income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 38184000.00
COVH.PA income_statement (annual, 2022-12-31) — Depreciation Income Statement: 38184000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 69878000.00
COVH.PA income_statement (annual, 2022-12-31) — Diluted Average Shares: 148131771.00
COVH.PA income_statement (annual, 2022-12-31) — Diluted EPS: 3.23
COVH.PA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 478790000.00
COVH.PA cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 3552000.00
COVH.PA income_statement (annual, 2022-12-31) — EBIT: 565225000.00
COVH.PA income_statement (annual, 2022-12-31) — EBITDA: 606369000.00
COVH.PA cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -920000.00
COVH.PA cash_flow (annual, 2022-12-31) — End Cash Position: 116985000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Financial Assets: 227343000.00
COVH.PA cash_flow (annual, 2022-12-31) — Financing Cash Flow: -383229000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Finished Goods: 144000.00
COVH.PA cash_flow (annual, 2022-12-31) — Free Cash Flow: 185826000.00
COVH.PA cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -296080000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Goodwill: 120096000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 120404000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 52612000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Gross PPE: 1133919000.00
COVH.PA income_statement (annual, 2022-12-31) — Gross Profit: 295182000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 50114000.00
COVH.PA income_statement (annual, 2022-12-31) — Interest Expense: 57599000.00
COVH.PA income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 57599000.00
COVH.PA income_statement (annual, 2022-12-31) — Interest Income: 1807000.00
COVH.PA income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1807000.00
COVH.PA cash_flow (annual, 2022-12-31) — Interest Paid Cff: -64736000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Inventory: 2346000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Invested Capital: 6081200000.00
COVH.PA cash_flow (annual, 2022-12-31) — Investing Cash Flow: 99994000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Investment Properties: 4937208000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 1157000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 211691000.00
COVH.PA cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
COVH.PA cash_flow (annual, 2022-12-31) — Issuance Of Debt: 44266000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 276148000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Long Term Debt: 2208845000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2484993000.00
COVH.PA cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 44266000.00
COVH.PA cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -216845000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 211691000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Minority Interest: 184679000.00
COVH.PA income_statement (annual, 2022-12-31) — Minority Interests: -23259000.00
COVH.PA cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -933000.00
COVH.PA cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -24000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Net Debt: 2375960000.00
COVH.PA income_statement (annual, 2022-12-31) — Net Income: 478790000.00
COVH.PA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 478790000.00
COVH.PA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 502048000.00
COVH.PA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 478790000.00
COVH.PA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 478790000.00
COVH.PA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 502048000.00
COVH.PA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 502048000.00
COVH.PA income_statement (annual, 2022-12-31) — Net Interest Income: -59947000.00
COVH.PA cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -172579000.00
COVH.PA cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -172579000.00
COVH.PA income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -59947000.00
COVH.PA cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -20989000.00
COVH.PA cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 1000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Net PPE: 1133919000.00
COVH.PA cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 97273000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 3457428000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 15966000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 247342000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 742000.00
COVH.PA income_statement (annual, 2022-12-31) — Normalized EBITDA: 399655000.00
COVH.PA income_statement (annual, 2022-12-31) — Normalized Income: 274347049.90
COVH.PA cash_flow (annual, 2022-12-31) — Operating Cash Flow: 256882000.00
COVH.PA income_statement (annual, 2022-12-31) — Operating Income: 249834000.00
COVH.PA income_statement (annual, 2022-12-31) — Operating Revenue: 466501000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 148130584.00
COVH.PA cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 38637000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 308000.00
COVH.PA cash_flow (annual, 2022-12-31) — Other Non Cash Items: 44887000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 8610000.00
COVH.PA income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -14000.00
COVH.PA income_statement (annual, 2022-12-31) — Other Operating Expenses: 11864000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Other Payable: 15945000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Other Properties: 17191000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Other Receivables: 31385000.00
COVH.PA income_statement (annual, 2022-12-31) — Other Special Charges: -3042000.00
COVH.PA income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
COVH.PA balance_sheet (annual, 2022-12-31) — Payables: 64329000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1284000.00
COVH.PA income_statement (annual, 2022-12-31) — Pretax Income: 507626000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Properties: 0.00
COVH.PA cash_flow (annual, 2022-12-31) — Purchase Of PPE: -71056000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Raw Materials: 2202000.00
COVH.PA income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 171319000.00
COVH.PA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 41144000.00
COVH.PA income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 2739000.00
COVH.PA cash_flow (annual, 2022-12-31) — Repayment Of Debt: -216845000.00
COVH.PA cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -24000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Retained Earnings: 478790000.00
COVH.PA cash_flow (annual, 2022-12-31) — Sale Of PPE: 168329000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Share Issued: 148141452.00
COVH.PA income_statement (annual, 2022-12-31) — Special Income Charges: 13785000.00
COVH.PA cash_flow (annual, 2022-12-31) — Stock Based Compensation: -79000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3577832000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 3457428000.00
COVH.PA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 2271049.90
COVH.PA income_statement (annual, 2022-12-31) — Tax Provision: 5577000.00
COVH.PA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.01
COVH.PA balance_sheet (annual, 2022-12-31) — Taxes Receivable: 26466000.00
COVH.PA cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -4070000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Total Assets: 7033995000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Total Capitalization: 5786677000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Total Debt: 2784769000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3762511000.00
COVH.PA income_statement (annual, 2022-12-31) — Total Expenses: 216667000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3271484000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 6714219000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2811565000.00
COVH.PA income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 260616000.00
COVH.PA income_statement (annual, 2022-12-31) — Total Other Finance Cost: 4155000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Total Tax Payable: 4896000.00
COVH.PA income_statement (annual, 2022-12-31) — Total Unusual Items: 206714000.00
COVH.PA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 206714000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 10868.00
COVH.PA balance_sheet (annual, 2022-12-31) — Treasury Stock: 161000.00
COVH.PA balance_sheet (annual, 2022-12-31) — Working Capital: -140143000.00
COVH.PA income_statement (annual, 2022-12-31) — Write Off: -10743000.00
COVH.PA income_statement (annual, 2023-12-31) — +Operating Expense: 43700000.00
COVH.PA income_statement (annual, 2023-12-31) — +Total Revenue: 551000000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Accounts Payable: 48400000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Accounts Receivable: 39500000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1659500000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -5759000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 161900000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 5300000.00
COVH.PA income_statement (annual, 2023-12-31) — Basic Average Shares: 148134973.00
COVH.PA income_statement (annual, 2023-12-31) — Basic EPS: -0.08
COVH.PA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 117000000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 1106700000.00
COVH.PA cash_flow (annual, 2023-12-31) — Capital Expenditure: -37800000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 288800000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Capital Stock: 592600000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 108800000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 108800000.00
COVH.PA cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -185200000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Cash Equivalents: 1500000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Cash Financial: 107300000.00
COVH.PA cash_flow (annual, 2023-12-31) — Change In Inventory: -100000.00
COVH.PA cash_flow (annual, 2023-12-31) — Change In Payable: 6600000.00
COVH.PA cash_flow (annual, 2023-12-31) — Change In Receivables: 13500000.00
COVH.PA cash_flow (annual, 2023-12-31) — Change In Working Capital: 20000000.00
COVH.PA cash_flow (annual, 2023-12-31) — Changes In Cash: -9300000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Common Stock: 592600000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3387100000.00
COVH.PA cash_flow (annual, 2023-12-31) — Common Stock Issuance: 100000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Construction In Progress: 10266000.00
COVH.PA income_statement (annual, 2023-12-31) — Cost Of Revenue: 218500000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Current Assets: 432800000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 5800000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Current Debt: 255900000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 261700000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Current Deferred Assets: 3447000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Current Liabilities: 425900000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Current Provisions: 600000.00
COVH.PA cash_flow (annual, 2023-12-31) — Deferred Tax: -34600000.00
COVH.PA cash_flow (annual, 2023-12-31) — Depreciation: 43200000.00
COVH.PA cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 43200000.00
COVH.PA income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 48200000.00
COVH.PA income_statement (annual, 2023-12-31) — Depreciation Income Statement: 48200000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 40900000.00
COVH.PA income_statement (annual, 2023-12-31) — Diluted Average Shares: 148134973.00
COVH.PA income_statement (annual, 2023-12-31) — Diluted EPS: -0.08
COVH.PA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -11600000.00
COVH.PA cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 5100000.00
COVH.PA income_statement (annual, 2023-12-31) — EBIT: 40700000.00
COVH.PA income_statement (annual, 2023-12-31) — EBITDA: 88900000.00
COVH.PA cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 900000.00
COVH.PA cash_flow (annual, 2023-12-31) — End Cash Position: 108700000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Financial Assets: 120300000.00
COVH.PA cash_flow (annual, 2023-12-31) — Financing Cash Flow: -327600000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Finished Goods: 200000.00
COVH.PA cash_flow (annual, 2023-12-31) — Free Cash Flow: 286300000.00
COVH.PA cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 264200000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Goodwill: 117400000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 117600000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 7400000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Gross PPE: 1109700000.00
COVH.PA income_statement (annual, 2023-12-31) — Gross Profit: 332500000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 57300000.00
COVH.PA income_statement (annual, 2023-12-31) — Interest Expense: 100600000.00
COVH.PA income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 100600000.00
COVH.PA income_statement (annual, 2023-12-31) — Interest Income: 4600000.00
COVH.PA income_statement (annual, 2023-12-31) — Interest Income Non Operating: 4600000.00
COVH.PA cash_flow (annual, 2023-12-31) — Interest Paid Cff: -77500000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Inventory: 2400000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Invested Capital: 5842000000.00
COVH.PA cash_flow (annual, 2023-12-31) — Investing Cash Flow: -5800000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Investment Properties: 4655200000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 5300000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 204600000.00
COVH.PA cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 100000.00
COVH.PA cash_flow (annual, 2023-12-31) — Issuance Of Debt: 624300000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 283000000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Long Term Debt: 2199000000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 2482000000.00
COVH.PA cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 624300000.00
COVH.PA cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -682600000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 204600000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Minority Interest: 163600000.00
COVH.PA income_statement (annual, 2023-12-31) — Minority Interests: 13700000.00
COVH.PA cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -41000.00
COVH.PA cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 100000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Net Debt: 2346100000.00
COVH.PA income_statement (annual, 2023-12-31) — Net Income: -11600000.00
COVH.PA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -11600000.00
COVH.PA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -25300000.00
COVH.PA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -11600000.00
COVH.PA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -11600000.00
COVH.PA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -25300000.00
COVH.PA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -25300000.00
COVH.PA income_statement (annual, 2023-12-31) — Net Interest Income: -100100000.00
COVH.PA cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -100000.00
COVH.PA cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -58300000.00
COVH.PA cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -58300000.00
COVH.PA income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -100100000.00
COVH.PA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 200000.00
COVH.PA cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -100000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Net PPE: 1109700000.00
COVH.PA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -13800000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 3269500000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 24000000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 210300000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 4700000.00
COVH.PA balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 2500000.00
COVH.PA income_statement (annual, 2023-12-31) — Normalized EBITDA: 134700000.00
COVH.PA income_statement (annual, 2023-12-31) — Normalized Income: 22750000.00
COVH.PA cash_flow (annual, 2023-12-31) — Operating Cash Flow: 324100000.00